2 (1)
2 (2)

ʻO Jymed Technot Co., LTD. E hauʻoli i ka hoʻolahaʻana i kāna huahana

Ka hana nui me ka maikaʻi kūpono

Wahi a JYYMED Text's Device Modegement ma mua,ʻo ka hana nui o ka hanaʻana o Tirzepatide i nā pae lāʻau lapaʻau. ʻO nā papa hana hana e paʻa ana a hoʻomau, me ka loli liʻiliʻiʻana ma waena o nā papa, e hōʻoia i ka maikaʻi maʻamau.

Nā hopena koʻikoʻi ma GLUCE a me ka hōʻemiʻana

ʻO Tirzepatide ka mea mua o ka honua iʻaeʻia i ka wā mua o ka honua-wiki E like me kahi Agonist Agonist, hiki iā ia ke hana i ka pūpū a hoʻoikaika i ka glucose a me ka gip-data a me ka gpl-1 i ke kino o ke kanaka. Ma ka hoʻohaʻahaʻaʻana i nā pae glucose, hōʻemi i ka eaʻaiʻai, ke kino kino, keʻano momona, a hoʻoponopono i ka hoʻohanaʻana i ka manawa. Ma waho o kāna mau hanana nui a me ka hoʻohaʻahaʻaʻana i nā hopena koʻikoʻi, nā loiloi morcroup mai nā umauma o nā papa hana i hōʻikeʻia e ke koko o nā metabolina e like me ke koko, bomi, a me nā lipi koko

Nā maʻi Multiinational a me ka hoʻolahaʻana i nā pōmaikaʻi

Wahi a kaʻike piliʻana, uaʻaeʻia ka mounjaro-haʻahaʻa-haʻahaʻa iʻaeʻia e ka US FDA ma Mei 2022 no ka mālamaʻana i nā pākeke me ka maʻi maʻi. Ua loaʻa iā ia i nā noi i loko o ka EU, Iapana, a me nā wahi'ē aʻe. I Novemaba 2023, uaʻaeʻo ka FDA i ka hōʻailona kaumaha ma lalo o ka inoa inoa inoa inoa inoa. I Mei 2024, ua komo pono ia i ka mākeke Kina. Hāʻawiʻia i kona mau mea kūʻai aku ākea ākea a me ke kākoʻoʻana i kaʻikepili noiʻi ikaika,ʻo Tirzepatide ua lilo kekahi o nā lāʻau lapaʻau nui loa i kēia lā. Ua hōʻeaʻia kona mau kūʻai aku i $ 5.163 Billion i 2023, aʻo ka hapa mua o 2024 wale nō e hele ana i keʻano nui o ka pīhoihoi.

E pili ana i ka jymed

2 (3)

Ua hoʻokumuʻiaʻo Shenzhen Jymed Techicic Coch, Ltd. Me ka Center noiʻi hoʻokahi a meʻekolu mau kumu hana hana nui,ʻo Jymed kekahi o nā mea hana nui o nā mea hana nui ma Kina. ʻO ka huiʻana o ka hui o kaʻoihana R & D Tual ma luna o 20 mau makahiki o kaʻike ma kaʻoihana Peptide a ua loaʻa i nā mea nānā FDA. Hāʻawiʻiaʻo JYMED a me ka pono o kaʻoihanaʻoihanaʻoihana e hāʻawi i nā mea kūʻai aku ma kahi o nā lawelawe piha, a me ka hanaʻana i nā pehu antimicial

Nā hana pāʻoihana nui

1.domestic a me ka hoʻopaʻa inoaʻana o ka APPide APIS

2. Loaʻa nā peptitic a me nā pettitic

3. Pepelue nā pehu a me nā cro, cmo, nā lawelaweʻo nā lawelawe

4.PDC mau lāʻau lapaʻau

Ma kahi o Tiromepatide,ʻo Jymed ua hāʻawi i nā huapalapala puke puke me ka FDA a me ka CD i nā huahana GLP-1ra e like me ka semaglutide a me nā liraglutude. ʻO nā mea kūʻai aku e pili ana i ka hoʻohanaʻana i nā huahana a Jymed e hiki ke kuhikuhi pololei i ka helu helu CDE a iʻole ka helu helu inoa inoa i ka wā e hoʻouna ai i nā noi kākau inoa i ka FDA a iʻole CDE. E hōʻemi nui kēia i ka manawa i koiʻia no nā palapala noi e hoʻomākaukau ana, a me ka manawa loiloi a me ke kumukūʻai o ka loiloi huahana.

2 (4)

Kāhea iā mā˚ou

2 (6)
2 (5)

Shenzhen Jymed Techisicic Co., Ltd.

Address:ʻO 8th & 9th papahele, kūkulu hale 1,ʻo Shenzhen biomedical noneagerialPark, Lahaina 14 Jinohi Ana Kengzi subditistricn, peszhen

Kelepona:+86 755-2661211

Pūnaewele: http://www.jymedtech.com/


Post Time: Aug-12-2024
TOP